Literature DB >> 26062634

Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery.

Peter H Albers1, Kirstine N Bojsen-Møller2, Carsten Dirksen2, Annette K Serup3, Dorte E Kristensen3, Jan Frystyk4, Trine R Clausen5, Bente Kiens3, Erik A Richter3, Sten Madsbad6, Jørgen F P Wojtaszewski7.   

Abstract

Roux-en-Y gastric bypass (RYGB) leads to increased peripheral insulin sensitivity. The aim of this study was to investigate the effect of RYGB on expression and regulation of proteins involved in regulation of peripheral glucose metabolism. Skeletal muscle and adipose tissue biopsies from glucose-tolerant and type 2 diabetic subjects at fasting and during a hyperinsulinemic-euglycemic clamp before as well as 1 wk and 3 and 12 mo after RYGB were analyzed for relevant insulin effector proteins/signaling components. Improvement in peripheral insulin sensitivity mainly occurred at 12 mo postsurgery when major weight loss was evident and occurred concomitantly with alterations in plasma adiponectin and in protein expression/signaling in peripheral tissues. In skeletal muscle, protein expression of GLUT4, phosphorylated levels of TBC1D4, as well as insulin-induced changes in phosphorylation of Akt and glycogen synthase activity were enhanced 12 mo postsurgery. In adipose tissue, protein expression of GLUT4, Akt2, TBC1D4, and acetyl-CoA carboxylase (ACC), phosphorylated levels of AMP-activated protein kinase and ACC, as well as insulin-induced changes in phosphorylation of Akt and TBC1D4, were enhanced 12 mo postsurgery. Adipose tissue from glucose-tolerant subjects was the most responsive to RYGB compared with type 2 diabetic patients, whereas changes in skeletal muscle were largely similar in these two groups. In conclusion, an improved molecular insulin-sensitive phenotype of skeletal muscle and adipose tissue appears to contribute to the improved whole body insulin action following a substantial weight loss after RYGB.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  bariatric surgery; insulin sensitivity; weight loss

Mesh:

Substances:

Year:  2015        PMID: 26062634     DOI: 10.1152/ajpregu.00228.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  20 in total

Review 1.  Does bariatric surgery improve adipose tissue function?

Authors:  H Frikke-Schmidt; R W O'Rourke; C N Lumeng; D A Sandoval; R J Seeley
Journal:  Obes Rev       Date:  2016-06-08       Impact factor: 9.213

Review 2.  Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 Diabetes.

Authors:  Eric M Desjardins; Gregory R Steinberg
Journal:  Curr Diab Rep       Date:  2018-08-17       Impact factor: 4.810

3.  The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control.

Authors:  Jonathan D Douros; Jenny Tong; David A D'Alessio
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

Review 4.  Bariatric Surgery in NAFLD.

Authors:  Mahak Chauhan; Kuldeep Singh; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2022-01-04       Impact factor: 3.199

Review 5.  Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery.

Authors:  J David Mosinski; John P Kirwan
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

6.  Cysteine- and glycine-rich protein 3 regulates glucose homeostasis in skeletal muscle.

Authors:  Angelina Hernandez-Carretero; Natalie Weber; Samuel A LaBarge; Veronika Peterka; Nhu Y Thi Doan; Simon Schenk; Olivia Osborn
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-04-10       Impact factor: 4.310

Review 7.  Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution?

Authors:  Chelsea R Hutch; Darleen A Sandoval
Journal:  Ann N Y Acad Sci       Date:  2016-09-26       Impact factor: 6.499

8.  Identification of Novel Changes in Human Skeletal Muscle Proteome After Roux-en-Y Gastric Bypass Surgery.

Authors:  Latoya E Campbell; Paul R Langlais; Samantha E Day; Richard L Coletta; Tonya R Benjamin; Elena Anna De Filippis; James A Madura; Lawrence J Mandarino; Lori R Roust; Dawn K Coletta
Journal:  Diabetes       Date:  2016-05-10       Impact factor: 9.461

9.  Alterations of sorbin and SH3 domain containing 3 (SORBS3) in human skeletal muscle following Roux-en-Y gastric bypass surgery.

Authors:  Samantha E Day; Luis A Garcia; Richard L Coletta; Latoya E Campbell; Tonya R Benjamin; Elena A De Filippis; James A Madura; Lawrence J Mandarino; Lori R Roust; Dawn K Coletta
Journal:  Clin Epigenetics       Date:  2017-09-02       Impact factor: 6.551

10.  Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes.

Authors:  Tang Cam Phung Pham; Kirstine Nyvold Bojsen-Møller; Sten Madsbad; Jørgen Frank Pind Wojtaszewski; Erik Arne Richter; Lykke Sylow
Journal:  Int J Obes (Lond)       Date:  2020-09-01       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.